CARDURION PHARMACEUTICALS

cardurion-pharmaceuticals-logo

Cardurion is a Boston-based cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. In July, 2017, Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new preclinical partnership to develop novel, next-generation therapeutics for the treatment of heart failure and cardiovascular diseases. The partnership with Cardurion follows Takedaโ€™s strategy to leverage external innovation by... placing selected assets and outstanding scientists in an entrepreneurial setting and enables the Discovery programs of Cardurion. In April 2018, Cardurion announced the Company entered an exclusive licensing agreement with Astellas to develop and commercialize CRD-733, a PDE-9 inhibitor with the potential to improve cardiac function in heart failure patients. With recent evidence supporting that inhibition of PDE-9 has potential to restore heart-protective mechanisms that are dysfunctional in heart failure, CRD-733 has the potential to address the cell-signaling breakdown that contributes to the progression of heart failure.

#SimilarOrganizations #People #Financial #Event #Website #More

CARDURION PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
2017-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.cardurion.com

Total Employee:
11+

Status:
Active

Contact:
617-996-1433

Email Addresses:
[email protected]

Total Funding:
325.65 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Nginx


Similar Organizations

cyagen-biosciences-logo

Cyagen Biosciences

Cyagen Biosciences is an emerging and innovative biotechnology company.

dizal-pharma-logo

Dizal Pharma

Dizal Pharma is a research-based biotechnology company.

emendo-biotherapeutics-logo

Emendo Biotherapeutics

Emendo Biotherapeutics is a biotechnology company

excellthera-logo

ExCellThera

ExCellThera is an advanced clinical stage biotechnology company.

kbp-biosciences-logo

KBP Biosciences

A multinational clinical stage biotechnology company.

neumora-therapeutics-logo

Neumora Therapeutics

Neumora Therapeutics operates as a clinical-stage biotechnology company.

panacea-biotec-logo

Panacea Biotec

Panacea Biotec is an Innovation driven Biotechnology company.

Current Employees Featured

marcia-moore_image

Marcia Moore
Marcia Moore Chief Operating Officer @ Cardurion Pharmaceuticals
Chief Operating Officer
2022-01-01

michael-mendelsohn_image

Michael Mendelsohn
Michael Mendelsohn Founder & Chairman @ Cardurion Pharmaceuticals
Founder & Chairman
2016-05-01

howard-surks_image

Howard Surks
Howard Surks Chief Medical Officer and Head of Translational Medicine @ Cardurion Pharmaceuticals
Chief Medical Officer and Head of Translational Medicine
2021-06-01

Founder


michael-mendelsohn_image

Michael Mendelsohn

Investors List

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series B - Cardurion Pharmaceuticals

bain-capital_image

Bain Capital

Bain Capital investment in Series B - Cardurion Pharmaceuticals

takeda-pharmaceutical_image

Takeda

Takeda investment in Series B - Cardurion Pharmaceuticals

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series A - Cardurion Pharmaceuticals

Official Site Inspections

http://www.cardurion.com Semrush global rank: 5.55 M Semrush visits lastest month: 1.53 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Cardurion Pharmaceuticals"

About Cardurion - Cardurion

Cardurion is at the forefront of discovering desperately needed new approaches to treating heart disease. We were founded by physician-scientists who possess world-class expertise in cardiovascular signaling pathways, and we couple โ€ฆSee details»

Cardurion Pharmaceuticals - Crunchbase Company โ€ฆ

Cardurion Pharmaceuticals is a Boston-based biotechnology company focused on developing novel therapeutics for the treatment of heart failure and other cardiovascular diseases. The company is advancing groundbreaking clinical โ€ฆSee details»

Leadership - Cardurion

Leadership Cardurion was founded by physician-scientist Michael E. Mendelsohn, M.D., and built by a team of physician-scientists and industry leaders with extensive experience in โ€ฆSee details»

Cardurion Company Profile 2025: Valuation, Funding

Cardurion General Information Description. Developer of cardiovascular therapeutics intended to treat cardiovascular diseases. The company's therapeutics offer advanced novel mechanisms to develop new treatments for โ€ฆSee details»

Cardurion Pharmaceuticals - Overview, News & Similar companies ...

Apr 19, 2023 Cardurion Pharmaceuticals is a biotechnology company focused on the discovery and development of next-generation therapeutics for the treatment of heart failure and other โ€ฆSee details»

Cardurion Pharmaceuticals Company Profile | Management and

Cardurion Pharmaceuticals Profile and History. Cardurion Pharmaceuticals is a biotechnology company focused on the discovery and development of next-generation therapeutics for the โ€ฆSee details»

Cardurion Pharmaceuticals Overview | SignalHire Company Profile

Cardurion Pharmaceuticals is a private company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. โ€ฆSee details»

Cardurion Pharmaceuticals - Contacts, Employees, Board Members ...

Organization. Cardurion Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Cardurion โ€ฆSee details»

Cardurion Pharma - VentureRadar

" Cardurion, a Boston-based, clinical-stage cardiovascular biotechnology company, is developing novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular โ€ฆSee details»

Cardurion Pharmaceuticals - Funding, Financials, Valuation

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases. ... How much funding has this organization raised โ€ฆSee details»

Cardurion Pharmaceuticals - Bain Capital Life Sciences

Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular โ€ฆSee details»

Cardurion Pharmaceuticals - Craft

Cardurion Pharmaceuticals is a cardiovascular biotechnology company offering therapeutics for the treatment of heart failure and cardiovascular diseases. It develops and commercializes โ€ฆSee details»

Cardurion Pharmaceuticals Selected as an Endpoints 11 Most โ€ฆ

Sep 27, 2024 BURLINGTON, Mass., September 27, 2024--Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics โ€ฆSee details»

Cardurion Pharmaceuticals Enhances Leadership Team with โ€ฆ

Feb 17, 2022 Brings More Than 30 Years of Pharmaceutical and Biotechnology Leadership Experience Supports Cardurionโ€™s Continued Advancement of Growing Pipeline of โ€ฆSee details»

Cardurion Management Team - CB Insights

Jeb is an independent director on the Boards of Cardurion Pharmaceuticals, a clinical-stage cardiovascular diseases company and Rome Therapeutics, an oncology-focused preclinical โ€ฆSee details»

Cardurion Pharmaceuticals - Work in biotech

Cardurion Pharmaceuticals is a next-generation cardiovascular biotech company founded by Dr. Michael E. Mendelsohn, a physician-Scientist with over 150 published articles. They focus on โ€ฆSee details»

Careers and Culture - Cardurion

Careers and Culture Turn Your Passion Into Impact at Cardurion Cardurionโ€™s company culture centers on fundamental values. We prioritize the needs of patients with cardiovascular disease โ€ฆSee details»

JPMorgan and BlackRock C-suite departure surprises show why

1 day ago Getting on the CEO successor shortlist could bring opportunities on its own, expert says.See details»

Research and Development - Cardurion

Research and Development Cardurion is dedicated to advancing novel mechanisms to create new treatments for cardiovascular disease, which remains the most significant cause of โ€ฆSee details»

Our Science - Cardurion

Our Science We translate our world-class expertise in cardiovascular signaling pathways into groundbreaking therapeutics At Cardurion, we are advancing the understanding of signaling โ€ฆSee details»

linkstock.net © 2022. All rights reserved